Pliant Therapeutics, Inc. (PLRX)
NASDAQ: PLRX · IEX Real-Time Price · USD
15.27
-0.34 (-2.18%)
May 17, 2024, 4:00 PM EDT - Market closed
Pliant Therapeutics Revenue
Pliant Therapeutics had revenue of $248.00K in the twelve months ending March 31, 2024, down -97.46% year-over-year. In the year 2023, Pliant Therapeutics had annual revenue of $1.58M, a decrease of -83.69%.
Revenue (ttm)
$248.00K
Revenue Growth
-97.46%
P/S Ratio
3,714.42
Revenue / Employee
$1,570
Employees
158
Market Cap
921.17M USD
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 1.58M | -8.11M | -83.69% |
Dec 31, 2022 | 9.69M | 2.11M | 27.91% |
Dec 31, 2021 | 7.57M | -34.25M | -81.89% |
Dec 31, 2020 | 41.82M | -15.24M | -26.70% |
Dec 31, 2019 | 57.05M | - | - |
Dec 31, 2018 | 0 | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
OPKO Health | 799.60M |
Avanos Medical | 680.10M |
Silk Road Medical | 185.49M |
Ocular Therapeutix | 59.84M |
Bicycle Therapeutics | 41.61M |
Relay Therapeutics | 35.33M |
Liquidia | 15.97M |
PLRX News
- 4 days ago - Pliant Therapeutics Announces Positive Topline Data from a Phase 2a Collagen PET Imaging Clinical Trial of Bexotegrast in Patients with Idiopathic Pulmonary Fibrosis - GlobeNewsWire
- 11 days ago - Pliant Therapeutics Announces Upcoming Presentations at the European Association for the Study of the Liver International Liver Congress™ - GlobeNewsWire
- 12 days ago - Pliant Therapeutics Provides Corporate Update and Reports First Quarter 2024 Financial Results - GlobeNewsWire
- 17 days ago - Pliant Therapeutics to Participate in Upcoming Investor Events - GlobeNewsWire
- 7 weeks ago - Pliant Therapeutics Announces Upcoming Presentations at the 2024 American Thoracic Society International Conference - GlobeNewsWire
- 2 months ago - Pliant Therapeutics Announces Accelerated Bexotegrast Development Plan for the Treatment of Idiopathic Pulmonary Fibrosis - GlobeNewsWire
- 2 months ago - Pliant Therapeutics Provides Corporate Update and Reports Fourth Quarter 2023 Financial Results - GlobeNewsWire
- 2 months ago - Pliant Therapeutics to Participate in Upcoming Investor Conferences - GlobeNewsWire